dopaminergic neuron
EVA-Score: Evaluation of Long-form Summarization on Informativeness through Extraction and Validation
Fan, Yuchen, Zhong, Xin, Wang, Chengsi, Wu, Gaoche, Zhou, Bowen
Summarization is a fundamental task in natural language processing (NLP) and since large language models (LLMs), such as GPT-4 and Claude, come out, increasing attention has been paid to long-form summarization whose input sequences are much longer, indicating more information contained. The current evaluation metrics either use similarity-based metrics like ROUGE and BERTScore which rely on similarity and fail to consider informativeness or LLM-based metrics, lacking quantitative analysis of information richness and are rather subjective. In this paper, we propose a new evaluation metric called EVA-Score using Atomic Fact Chain Generation and Document-level Relation Extraction together to automatically calculate the informativeness and give a definite number as an information score. Experiment results show that our metric shows a state-of-the-art correlation with humans. We also re-evaluate the performance of LLMs on long-form summarization comprehensively from the information aspect, forecasting future ways to use LLMs for long-form summarization.
Self-supervised Learning for Segmentation and Quantification of Dopamine Neurons in Parkinson's Disease
Haghighi, Fatemeh, Ghosh, Soumitra, Ngu, Hai, Chu, Sarah, Lin, Han, Hejrati, Mohsen, Bingol, Baris, Hashemifar, Somaye
Parkinson's Disease (PD) is the second most common neurodegenerative disease in humans. PD is characterized by the gradual loss of dopaminergic neurons in the Substantia Nigra (SN). Counting the number of dopaminergic neurons in the SN is one of the most important indexes in evaluating drug efficacy in PD animal models. Currently, analyzing and quantifying dopaminergic neurons is conducted manually by experts through analysis of digital pathology images which is laborious, time-consuming, and highly subjective. As such, a reliable and unbiased automated system is demanded for the quantification of dopaminergic neurons in digital pathology images. Recent years have seen a surge in adopting deep learning solutions in medical image processing. However, developing high-performing deep learning models hinges on the availability of large-scale, high-quality annotated data, which can be expensive to acquire, especially in applications like digital pathology image analysis. To this end, we propose an end-to-end deep learning framework based on self-supervised learning for the segmentation and quantification of dopaminergic neurons in PD animal models. To the best of our knowledge, this is the first deep learning model that detects the cell body of dopaminergic neurons, counts the number of dopaminergic neurons, and provides characteristics of individual dopaminergic neurons as a numerical output. Extensive experiments demonstrate the effectiveness of our model in quantifying neurons with high precision, which can provide a faster turnaround for drug efficacy studies, better understanding of dopaminergic neuronal health status, and unbiased results in PD pre-clinical research. As part of our contributions, we also provide the first publicly available dataset of histology digital images along with expert annotations for the segmentation of TH-positive DA neuronal soma.
Scientists eliminate Parkinson's disease in mice
A breakthrough that led to the creation of new neurons in mice could be used to transplant brain cells in Parkinson's patients and cure them of the disease. University of California San Diego School of Medicine researchers created neurons in mice using a new, much simpler method that involved rewriting genes. Parkinson's disease is characterised by a loss of dopaminergic neurons in a region of the brain responsible for reward and movement - replacing those cells could help to reduce or even reverse the symptoms of the degenerative disease. A small study involving mice with Parkinson's saw those given the'new neuron treatment' return to normal within three months and stay disease free for life. The researchers said it could one day be used to'cure' any disease caused by the loss of neurons but warned this was a long way off and hadn't been tested. Left: mouse cells (green) before reprogramming and then right shows neurons (red) induced from mouse cells after reprogramming.
The Brain Predicts Reward Like an AI, Says New DeepMind Research
The idea of reinforcement learning--or learning based on reward--has been around for so long it's easy to forget we don't really know how it works. If DeepMind's new bombshell paper in Nature is any indication, a common approach in AI, one that's led to humanity's defeat in the game of Go against machines, may have the answer. We all subconsciously learn complex behaviors in response to positive and negative feedback, but how that works in the brain remains a century-long mystery. By examining a powerful variant of reinforcement learning, dubbed distributional reinforcement learning, that outperforms original methods, the team suggests that the brain may simultaneously represent multiple predicted futures in parallel. Each future is assigned a different probability, or chance of actually occurring, based on reward.